Langerhans cells down-regulate inflammation-driven alveolar bone loss

Area of Science:

• Immunology
• Oral Biology
• Bone Biology

Background:

• Chronic infections and inflammation can cause excessive bone resorption.
• T cells are known to promote osteoclastogenesis, but the role of dendritic cells, particularly Langerhans cells (LCs), in this process is unclear.

Purpose of the Study:

• To investigate the role of Langerhans cells (LCs) in inflammation-driven alveolar bone loss.

Main Methods:

• Utilized a mouse model of infection-induced alveolar bone loss.
• In vivo ablation of Langerhans cells (LCs).
• Analyzed immune cell infiltration, T cell activation, cytokine production, and bone homeostasis markers.

Main Results:

• LC ablation led to enhanced alveolar bone loss.
• Increased infiltration of T and B lymphocytes, including RANKL-expressing CD4+ T cells, was observed in LC-ablated mice.
• Absence of LCs resulted in elevated CD4+ T cell activation and increased IFN-γ production, without affecting CD8+ T cells.

Conclusions:

• Langerhans cells (LCs) play a protective immunoregulatory role in inflammation-induced alveolar bone resorption.
• LCs inhibit excessive activation of RANKL+ CD4+ T cells and IFN-γ secretion, thereby preventing enhanced osteoclastogenesis.